CoChat
Sign Up
Cited by 125Attention Deficit Hyperactivity DisorderPharmaceutical studies and practicesPharmacology and Obesity Treatment

The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.

Does Prolonged Therapy With a Long-Acting Stimulant Suppress Growth in Children With ADHD?

SPENCER, THOMAS J., FARAONE, STEPHEN V., BIEDERMAN, JOSEPH, LERNER, MARC, COOPER, KIMBERLY M., ZIMMERMAN, BRENDA·2006·Journal of the American Academy of Child & Adolescent Psychiatry
DOI 10.1097/01.chi.0000205710.01690.d4
Open this paper in CoChat — free account

Abstract

Objective To investigate whether prolonged therapy with a long-acting stimulant affects growth in children with attention-deficit/hyperactivity disorder (ADHD).Method One hundred seventy-eight children ages 6 to 13 years received OROS methylphenidate (OROS MPH, CONCERTA) for at least 21 months. Height and weight were measured monthly during the first year and every 3 months thereafter.Results At baseline, subjects were approximately the expected height for their age and somewhat heavier than expected. Subjects gained height steadily throughout the study and were on average 0.23 cm less than expected at month 21. Weight did not increase and BMI decreased slightly in the first 4 months. Thereafter, weight Z score and BMI Z score remained relatively constant and children were on average 1.23 kg less than expected at month 21. Previous stimulant therapy tended to be associated with a smaller decrease in Z score during the study compared with no previous stimulant therapy. Drug holidays did not significantly affect growth.Conclusions The effects of prolonged OROS MPH therapy on growth were clinically insignificant and limited to slight decreases in weight during the first months of therapy. Drug holidays did not reduce any impact on growth and are thus of questionable utility for limiting potential effects of treatment on growth.

Overview

Integrity signals

Registry

Crossref · 10.1097/01.chi.0000205710.01690.d4

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 41 references

Research works printed but not linked: 2

  1. Baren, 2000, Lack of effect of different breakfast conditions on the pharmacokinetics and efficacy of OROS methylphenidate HCl extended-release tablets in children with ADHD, Pediatr Res, 47, 23A
  2. Swanson, 2000, Initiating CONCERTA (OROS methylphenidate HCI) qd in children with attention-deficit hyperactivity disorder, J Clin Res, 3, 59

Cited by

Sorted by citations

Items 101–124 of 124

Related

See all

Metadata

Authors
SPENCER, T. J., FARAONE, S. V., BIEDERMAN, J., LERNER, M., COOPER, K. M., & ZIMMERMAN, B.
Affiliations
SUNY Upstate Medical University (US)
Corresponding author
SPENCER, THOMAS J.
ORCID
Venue
Journal of the American Academy of Child & Adolescent Psychiatry
Publisher
Elsevier BV
Published
2006-05
Volume
45
Issue
5
Pages
527-537
ISSN
0890-8567 (ISSN-L)
DOI
10.1097/01.chi.0000205710.01690.d4
OpenAlex
W2077454035
Cited by
125
References
41
Citations by year
2026: 1 · 2025: 1 · 2024: 1 · 2023: 4 · 2022: 3 · 2021: 4 · 2020: 4 · 2019: 5 · 2018: 7 · 2017: 3 · 2016: 2 · 2015: 9 · 2014: 12 · 2013: 2 · 2012: 6
FWCI
9.54
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • Journal of the American Academy of Child & Adolescent Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmaceutical studies and practices
  • Health Sciences › Medicine › Pharmacology (medical) › Pharmacology and Obesity Treatment
Keywords
attention deficit hyperactivity disorder, long-acting stimulants, OROS methylphenidate, growth inhibition, height, weight, body mass index, drug holidays, children
MeSH terms
Central Nervous System Stimulants, Attention Deficit Disorder with Hyperactivity, Body Height, Body Weight, Child, Clinical Trials as Topic, Delayed-Action Preparations, Dose-Response Relationship, Drug, Female, Follow-Up Studies, Humans, Long-Term Care, Male, Methylphenidate, Body Mass Index

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review